Cargando…
Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination
SARS-CoV-2 infection is associated with an increased rate of thromboembolic events and mortality. Different vaccines are globally used to limit the pandemic. In this report, we present the case of two young female patients with newly diagnosed cerebral sinus vein thrombosis occurring after injection...
Autores principales: | Fousse, Mathias, Schub, David, Merzou, Fatma, Fassbender, Klaus, Sester, Martina, Kettner, Michael, Lochner, Piergiorgio, Schmidt, Tina, Goi Júnior, João Reinoldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491181/ https://www.ncbi.nlm.nih.gov/pubmed/34609603 http://dx.doi.org/10.1007/s00415-021-10731-2 |
Ejemplares similares
-
Rare cerebral vein thrombosis and COVID-19 vaccine: the role of orbit ultrasound
por: Lochner, Piergiorgio, et al.
Publicado: (2022) -
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021) -
Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure
por: Wolf, Marc E., et al.
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)